1. Relevé épidémiologique hebdomadaire. No. 51/52, 2006, 81, 469–480.

  2. Relevé épidémiologique hebdomadaire. No. 9, 2012, 87, 73–80

  3. Speziani C, Laine D, Servet-Delprat C, Valentin H, Rabourdin-Combe C. Virus de la rougeole et immunosuppression. Med Mal Infect 2004 ; 34 (s1) 2-6.

  4. World Health Organization. The global burden of disease: 2004 update. 2004. WHO Press, Geneva 27, Switzerland, World Health organization WHO.

  5. Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiology. 2009;38:192–205.

  6. Grais RF, Dubray C, Gerstl S, Guthmann JP, Djibo A, Nargaye KD, Coker J, Alberti KP, Cochet A, Ihekweazu C, Nathan N, Payne L, Porten K, Sauvageot D, Schimmer B, Fermon F, Burny ME, Hersh BS, Guerin PJ. Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med. 2007 Jan;4(1):e16.

  7. Malfait P, Jataou IM, Jollet MC, et al. Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. Pediatr Infect Dis J 1994; 13:38-45.

  8. Grais R.F., et al. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006. 100(9): p. 867-873.

  9. Broutin H., et al. Epidemiological impact of vaccination on the dynamics of two childhood diseases in rural Senegal. Microbes and Infection, 2005. 7(4): p. 593-599.

  10. Ferrari M. J., Grais R. F., Bharti N., Conlan A. J. K., Bjørnstad O. N., Wolfson L. J., Guerin P. J., Djibo A., Grenfell B. T. 2008. The dynamics of measles in sub-Saharan Africa. Nature 451, 679–684.

  11. Grais RF, DE Radiguès X, Dubray C, Fermon F, Guerin PJ. Exploring the time to intervene. Epidemiol Infect. 2006 Aug;134(4):845-9. Epub 2006 Jan 26.

  12. Grais RF, Conlan AJ, Ferrari MJ, Djibo A, Le Menach A, Bjørnstad ON, Grenfell BT. Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface. 2008 Jan 6;5(18):67-74.

  13. Dubray C, Gervelmeyer A, Djibo A, Jeanne I, Fermon F, Soulier MH, Grais RF, Guerin PJ. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Vaccine. 2006 May 1;24(18):3984-9. Epub 2006 Feb 8.

  14. Pinquier D., et al. Distribution of serum measles-neutralizing antibodies according to age in women of childbearing age in France in 2005-2006: impact of routine immunization. Pediatr Infect Dis J 26(8):749-50 (2007).

  15. Bhaskaram P. Measles and malnutrition. Indian J Med Res. 1995 Nov;102:195-9.

  16. Scott P, Moss WJ, Gilani Z, Low N. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78. doi: 10.1093/infdis/jir071.

  17. Centers for Disease Control and Prevention. General Recommendations on Immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. December 1, 2006 / Vol. 55 / No. RR-15.

  18. World Health Organization. Manual for the laboratory diagnosis of measles and rubella infection, 2nd ed. CH-1211 Geneva 27, Switzerland (WHO/IVB/07.01).

  19. World Health Organization. Response to measles outbreaks in measles mortality reduction settings. CH-1211 Geneva 27, Switzerland. WHO/IVB/09.03

  20. Ferrari M. J., Djibo A., Grais R. F., Grenfell B. T., Bjørnstad O. N. Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example. Epidemiology and Infection / Volume 138 / Issue 01 / January 2010, pp 108-116.

  21. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1;189 Suppl 1:S4-16.

  22. Organisation mondiale de la Santé. L’enfant, la rougeole et l’œil. CH-1211 Genève 27, Suisse. WHO/EPI/TRAM/93.05 (mise à jour 2004).

  23. May-Lill Garly, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ, doi:10.1136/bmj.38989.684178.AE(published 23 October 2006).

  24. Luquero FJ, Pham-Orsetti H, Cummings DA, Ngaunji PE, Nimpa M, Fermon F, Ngoe N, Sosler S, Strebel P, Grais RF. A long-lasting measles epidemic in Maroua, Cameroon 2008- 2009: mass vaccination as response to the epidemic. J Infect Dis. 2011 Jul;204 Suppl 1:S243-51. doi: 10.1093/infdis/jir093.